These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 10652169)

  • 1. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia.
    Fobi G; Gardon J; Santiago M; Ngangue D; Gardon-Wendel N; Boussinesq M
    Ophthalmic Epidemiol; 2000 Mar; 7(1):27-39. PubMed ID: 10652169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events.
    Kamgno J; Pion SD; Mackenzie CD; Thylefors B; Boussinesq M
    Am J Trop Med Hyg; 2009 Dec; 81(6):1056-61. PubMed ID: 19996437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
    Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
    Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp.
    Kamgno J; Boussinesq M; Labrousse F; Nkegoum B; Thylefors BI; Mackenzie CD
    Am J Trop Med Hyg; 2008 Apr; 78(4):546-51. PubMed ID: 18385346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Release of Loa loa antigens after treatment with ivermectin].
    Chippaux JP; Nkinin SW; Gardon-Wendel N; Ducorps M
    Bull Soc Pathol Exot; 1998; 91(4):297-9. PubMed ID: 9846220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of loiasis and outcomes of ivermectin masstreatment in Ijebu-North, Nigeria.
    Hassan AA; Akinsanya B; Iyase N; Owagboriaye FO
    Korean J Parasitol; 2011 Jun; 49(2):153-9. PubMed ID: 21738271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retinal hemorrhages after ivermectin treatment for onchocerciasis in a patient with Loa loa microfilaremia].
    Moussala M; Fobi G; Ongolo Zogo P; Bella Hiag LA; Bengono G; McMoli TE
    J Fr Ophtalmol; 2004 Jan; 27(1):63-6. PubMed ID: 14968080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
    Boussinesq M; Gardon J; Kamgno J; Pion SD; Gardon-Wendel N; Chippaux JP
    Ann Trop Med Parasitol; 2001 Jul; 95(5):495-507. PubMed ID: 11487371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid assessment method for prevalence and intensity of Loa loa infection.
    Takougang I; Meremikwu M; Wandji S; Yenshu EV; Aripko B; Lamlenn SB; Eka BL; Enyong P; Meli J; Kale O; Remme JH
    Bull World Health Organ; 2002; 80(11):852-8. PubMed ID: 12481206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin for treating post-ivermectin Loa-related serious adverse events?
    Boussinesq M; Kamgno J; Pion SD; Mackenzie CD
    Trends Parasitol; 2010 Jan; 26(1):4-5. PubMed ID: 19879192
    [No Abstract]   [Full Text] [Related]  

  • 12. Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events.
    Fokom-Domgue J; Pion SD; Gounoue R; Akame J; Nguipdop-Djomo P; Twum-Danso NA; Thylefors B; Boussinesq M; Kamgno J
    Am J Trop Med Hyg; 2014 Feb; 90(2):335-8. PubMed ID: 24420781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loa loa and Mansonella perstans infections in Ijebu north, western Nigeria: a parasitological study.
    Agbolade M; Akinboye DO
    Jpn J Infect Dis; 2001 Jun; 54(3):108-10. PubMed ID: 11544400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
    Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term action of multiple doses of ivermectin on loiasis microfilaremia.
    Kombila M; Duong TH; Ferrer A; Perret JL; Marion MC; Nguiri C; Gaxotte P; Manfoumbi M; Richard-Lenoble D
    Am J Trop Med Hyg; 1998 Apr; 58(4):458-60. PubMed ID: 9574792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon.
    Wanji S; Tendongfor N; Esum M; Ndindeng S; Enyong P
    Med Microbiol Immunol; 2003 Feb; 192(1):15-21. PubMed ID: 12592559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment.
    Wanji S; Eyong EJ; Tendongfor N; Ngwa CJ; Esuka EN; Kengne-Ouafo AJ; Datchoua-Poutcheu FR; Enyong P; Agnew D; Eversole RR; Hopkins A; Mackenzie CD
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005576. PubMed ID: 28686693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between microfilaraemic and amicrofilaraemic loiasis involving co-infection with Mansonella perstans and clinical symptoms in an exposed population from Gabon.
    Bouyou Akotet MK; Owono-Medang M; Mawili-Mboumba DP; Moussavou-Boussougou MN; Nzenze Afène S; Kendjo E; Kombila M
    J Helminthol; 2016 Jul; 90(4):469-75. PubMed ID: 26268068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
    Boussinesq M; Gardon J; Gardon-Wendel N; Kamgno J; Ngoumou P; Chippaux JP
    Am J Trop Med Hyg; 1998 Apr; 58(4):461-9. PubMed ID: 9574793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.